Wanten Geert
Universitair Medisch Centrum St. Radboud, Darmfalen Unit, afd. Maag-, Darm-, en Leverziekten, Nijmegen, the Netherlands.
Ned Tijdschr Geneeskd. 2010;154:A2316.
Omega-3 fatty acids derived from fish oil have constantly been in the limelight in recent years because of their beneficial effects on health. In the field of parenteral nutrition, fish oil-based lipid emulsions also have shown very promising results with regard to parenteral-nutrition-associated liver disease (PNALD) and in comparison with soybean-oil derived emulsions. The latter are especially rich in omega-6 fatty acids, with pro-inflammatory characteristics. It is not clear, however, which effects can be attributed to the omega-3 fatty acids in fish oil, with their anti-inflammatory profile, since studies employed different lipid doses for soybean- and fish oil emulsions. In addition, antioxidants and potentially toxic plant sterols play a role. There is a clear need for adequate controlled studies to clarify these effects.
近年来,源自鱼油的Omega-3脂肪酸因其对健康的有益作用而一直备受关注。在肠外营养领域,基于鱼油的脂质乳剂在与肠外营养相关的肝病(PNALD)方面以及与大豆油衍生的乳剂相比也显示出非常有前景的结果。后者富含具有促炎特性的Omega-6脂肪酸。然而,尚不清楚鱼油中的Omega-3脂肪酸凭借其抗炎特性会产生哪些作用,因为研究对大豆油和鱼油乳剂使用了不同的脂质剂量。此外,抗氧化剂和潜在有毒的植物甾醇也起作用。显然需要进行充分的对照研究来阐明这些作用。